Assay for maprotiline in human serum with improved sensitivity and selectivity.
The use of a photoreactor and fluorescence detection enables measurement of the tetracyclic antidepressant drug 3-(9,10-dihydro-9,10-ethanoanthracene-9-yl)-N-methylpropylamine (maprotiline) with a sensitivity of 100 pg/ml serum. This detection system is highly specific and enables the measurement of very low concentrations in the presence of high concentrations of other drugs that are often found in patient samples. The mean free portions of maprotiline and desmethylmaprotiline were found to be 2.2% and 1.5%, respectively.
Kuss
H J
HJ
Department of Neurochemistry, Psychiatric Hospital, University of Munich, Germany.
Sirch
S
S
Zhao
D Y
DY
D006207:Half-Life; D006801:Humans; D007202:Indicators and Reagents; D008376:Maprotiline / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics; D013050:Spectrometry, Fluorescence; D013056:Spectrophotometry, Ultraviolet; D014462:Ultrafiltration
D007202:Indicators and Reagents; D008376:Maprotiline; C027056:desmethylmaprotiline